Dorman Followwill serves as Executive at Sorrento Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Dorman Followwill has executed 3 insider transactions totaling $7.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 26, 2024 involved exercising options for 1,000 shares valued at $1.4K.
Dorman Followwill currently holds 1,300 shares of Sorrento Therapeutics, Inc. (SRNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dorman Followwill has been a net seller of SRNE stock. They have purchased $0 and sold $7.1K worth of shares.
Dorman Followwill's most recent insider trade was on Jun 26, 2024, when they sold 1,000 shares at $1.37 per share.
Get notified when new Form 4 filings are submitted
| $7.14 |
| Discretionary |
| Nov 11, 2020 | SRNE | $0 | Will Acquisition | 1,000 | $N/A | Discretionary |